Cancer Progress by Cello Health
Defined Health has a deep knowledge base within and across all therapeutic categories. The focus of our work closely mirrors the therapeutic area focus of today’s biopharmaceutical pipeline.
Rachel Haurwitz, PhD, Chief Executive Officer, and Founder, Caribou
Tim van Hauwermeiren (arGEN-X), Yibin Kang (Princeton University), Brian Leyland-Jones (Avera Cancer Institute), Axel Hoos (GSK), Hapreet Singh (Immatics), John Haurum (f-Star), Ji Li (Lilly Asia Ventures), Weimin Tang (I-Mab Biopharma).
For More Information:
Defined Health’s Insight Series Webinar
Moderator: James Lee, PhD, Associate Principal, Oncology Lead, Defined Health
To register and to learn more about the webinar visit: